Advanced search
Publication Cover
Brain Injury Volume 35, 2021 - Issue 10
Submit an article Journal homepage
155
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Circ_0062166 aggravates cerebral ischemia-reperfusion injury through targeting miR-526b-5p/BCL2L13 axis

Zhenwei GuoDepartment of Neurology, Lianyungang Clinical Medical College of Nanjing Medical University, The First People’s Hospital of Lianyungang City, Lianyungang, Jiangsu, China
,
Guanghui ZhangDepartment of Neurology, Lianyungang Clinical Medical College of Nanjing Medical University, The First People’s Hospital of Lianyungang City, Lianyungang, Jiangsu, China
,
Bingchao XuDepartment of Neurology, Lianyungang Clinical Medical College of Nanjing Medical University, The First People’s Hospital of Lianyungang City, Lianyungang, Jiangsu, China
,
Chunyang ZhangDepartment of Neurology, Lianyungang Clinical Medical College of Nanjing Medical University, The First People’s Hospital of Lianyungang City, Lianyungang, Jiangsu, China
,
Aihua TaoDepartment of Neurology, Lianyungang Clinical Medical College of Nanjing Medical University, The First People’s Hospital of Lianyungang City, Lianyungang, Jiangsu, China
,
Mingli HeDepartment of Neurology, Lianyungang Clinical Medical College of Nanjing Medical University, The First People’s Hospital of Lianyungang City, Lianyungang, Jiangsu, China
&
Xiaobing HeDepartment of Neurology, Lianyungang Clinical Medical College of Nanjing Medical University, The First People’s Hospital of Lianyungang City, Lianyungang, Jiangsu, ChinaCorrespondence[email protected]
 show all
Pages 1245-1253 | Received 09 Nov 2020, Accepted 02 Jul 2021, Published online: 08 Sep 2021

References

  • Jean WC, Spellman SR, Nussbaum ES, Low WC. Reperfusion injury after focal cerebral ischemia: the role of inflammation and the therapeutic horizon. Neurosurgery. 1998 Dec;43(6):1382–96; discussion 1396–7.
  • Sveinsson OA, Kjartansson O, Valdimarsson EM. [Cerebral ischemia/infarction - epidemiology, causes and symptoms]. Laeknabladid. 2014 May;100(5):271–79.
  • Katan M, Luft A. Global Burden of Stroke. Semin Neurol. 2018 Apr;38(2):208–11. doi:10.1055/s-0038-1649503.
  • Mukherjee D, Patil CG. Epidemiology and the global burden of stroke. World Neurosurg. 2011 Dec;76(6 Suppl):S85–90. doi:10.1016/j.wneu.2011.07.023.
  • Kristensen LS, Andersen MS, Stagsted LVW, Ebbesen KK, Hansen TB, Kjems J. The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet. 2019 Nov;20(11):675–91. doi:10.1038/s41576-019-0158-7.
  • Gao JL, Chen G, He HQ, Wang J. [CircRNA as a new field in human disease research]. China J Chin Mater Med. 2018 Feb;43(3):457–62.
  • Yu L, Liu Y. circRNA_0016624 could sponge miR-98 to regulate BMP2 expression in postmenopausal osteoporosis. Biochem Biophys Res Commun. 2019 Aug 20;516(2):546–50. doi: 10.1016/j.bbrc.2019.06.087.
  • Lu Q, Liu T, Feng H, Yang R, Zhao X, Chen W, Jiang B, Qin H, Guo X, Liu M, et al. Circular RNA circSLC8A1 acts as a sponge of miR-130b/miR-494 in suppressing bladder cancer progression via regulating PTEN. Mol Cancer. 2019 Jun 22;18(1):111. doi:10.1186/s12943-019-1040-0.
  • Jiao J, Zhang T, Jiao X, Huang T, Zhao L, Ma D, Cui B. hsa_circ_0000745 promotes cervical cancer by increasing cell proliferation, migration, and invasion. J Cell Physiol. 2020 Feb;235(2):1287–95. doi:10.1002/jcp.29045.
  • Yang J, Chen M, Cao RY, Li Q, Zhu F. The role of circular RNAs in cerebral ischemic diseases: ischemic stroke and cerebral ischemia/reperfusion injury. Adv Exp Med Biol. 2018;1087:309–25.
  • Yang X, Ji H, Yao Y, Lai X, Jiang Y, Wu D, Cai L, Zhu W, Gu X, Hu R, et al. Downregulation of circ_008018 protects against cerebral ischemia-reperfusion injury by targeting miR-99a. Biochem Biophys Res Commun. 2018 May 23;499(4):758–64. doi:10.1016/j.bbrc.2018.03.218.
  • Cao Y, Liu H, Zhang J, Dong Y. Circular RNA cZNF292 silence alleviates OGD/R-induced injury through up-regulation of miR-22 in rat neural stem cells (NSCs). Artif Cells Nanomed Biotechnol. 2020 Dec;48(1):594–601. doi:10.1080/21691401.2020.1725536.
  • Jiang D, Sun X, Wang S, Man H. Upregulation of miR-874-3p decreases cerebral ischemia/reperfusion injury by directly targeting BMF and BCL2L13. Biomed Pharmacother. 2019 Sep;117:108941. doi:10.1016/j.biopha.2019.108941.
  • Lu Y, Han Y, He J, Zhou B, Fang P, Li X. LncRNA FOXD3-AS1 knockdown protects against cerebral ischemia/reperfusion injury via miR-765/BCL2L13 axis. Biomed Pharmacother. 2020 Oct 14;132:110778. doi:10.1016/j.biopha.2020.110778.
  • Shao T, Pan YH, Xiong XD. Circular RNA: an important player with multiple facets to regulate its parental gene expression. Mol Ther Nucleic Acids. 2021 Mar 5;23:369–76. doi:10.1016/j.omtn.2020.11.008.
  • Zhang ZH, Wang YR, Li F, Liu X-L, Zhang H, Zhu -Z-Z, Huang H, Xu X-H. Circ-camk4 involved in cerebral ischemia/reperfusion induced neuronal injury. Sci Rep. 2020 Apr 24;10(1):7012. doi:10.1038/s41598-020-63686-1.
  • Zhang X, Huang CR, Pan S, Pang Y, Chen Y-S, Zha G-C, Guo K-J, Zheng X. Long non-coding RNA SNHG15 is a competing endogenous RNA of miR-141-3p that prevents osteoarthritis progression by upregulating BCL2L13 expression. Int Immunopharmacol. 2020 Jun;83:106425. doi:10.1016/j.intimp.2020.106425.
  • Jensen SA, Calvert AE, Volpert G, Kouri FM, Hurley LA, Luciano JP, Wu Y, Chalastanis A, Futerman AH, Stegh AH, et al. Bcl2L13 is a ceramide synthase inhibitor in glioblastoma. Proc Natl Acad Sci U S A. 2014 Apr 15;111(15):5682–87. doi:10.1073/pnas.1316700111.
  • Mitra A, Pfeifer K, Park KS. Circular RNAs and competing endogenous RNA (ceRNA) networks. Transl Cancer Res. 2018 Jun;7(Suppl 5):S624–s628. doi:10.21037/tcr.2018.05.12.
  • Zhao W, Cui Y, Liu L, Qi X, Liu J, Ma S, Hu X, Zhang Z, Wang Y, Li H, et al. Splicing factor derived circular RNA circUHRF1 accelerates oral squamous cell carcinoma tumorigenesis via feedback loop. Cell Death Differ. 2020 Mar;27(3):919–33. doi:10.1038/s41418-019-0423-5.
  • Liu P, Liu W, Gao H, Zhang Y, Yan M, Wang X. Circ0085539 promotes osteosarcoma progression by suppressing miR-526b-5p and PHLDA1 axis. Front Oncol. 2020;10:1250.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.